Skip to main content
Fig. 1 | BMC Cancer

Fig. 1

From: Protocol for the postoperative radiotherapy in N1 breast cancer patients (PORT-N1) trial, a prospective multicenter, randomized, controlled, non-inferiority trial of patients receiving breast-conserving surgery or mastectomy

Fig. 1

Schematic diagram of the design of the Postoperative Radiotherapy in N1 Breast Cancer Patients (PORT-N1) trial of patients receiving breast-conserving surgery (BCS) or mastectomy. CIN, cervical intraepithelial neoplasia; ECOG, Eastern Cooperative Oncology Group; ER, estrogen receptor; HER2, human epidermal growth factor receptor 2; PMRT, post-mastectomy radiotherapy; PR, progesterone receptor; TM, total mastectomy; RT, radiation therapy; TNBC, triple-negative breast cancer; WBI, whole-breast irradiation

Back to article page